1. Home
  2. LEE vs PPCB Comparison

LEE vs PPCB Comparison

Compare LEE & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lee Enterprises Incorporated

LEE

Lee Enterprises Incorporated

HOLD

Current Price

$4.01

Market Cap

24.7M

ML Signal

HOLD

PPCB

Propanc Biopharma Inc.

N/A

Current Price

$0.76

Market Cap

20.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
LEE
PPCB
Founded
1890
2007
Country
United States
Australia
Employees
N/A
N/A
Industry
Newspapers/Magazines
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
24.7M
20.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LEE
PPCB
Price
$4.01
$0.76
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
17.5K
263.2K
Earning Date
11-26-2025
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$562,341,000.00
N/A
Revenue This Year
$5.48
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.70
$0.73
52 Week High
$16.84
$145.46

Technical Indicators

Market Signals
Indicator
LEE
PPCB
Relative Strength Index (RSI) 39.28 N/A
Support Level $3.90 N/A
Resistance Level $4.43 N/A
Average True Range (ATR) 0.38 0.00
MACD -0.00 0.00
Stochastic Oscillator 2.73 0.00

Price Performance

Historical Comparison
LEE
PPCB

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: